What are the common side effects of ibrutinib/ibrutinib and how should they be dealt with?

Ibrutinib is a targeted anti-cancer drug, mainly suitable for the treatment of B-cell malignant tumors such as mantle cell lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma and Waldenstrom's macroglobulinemia. It inhibits the activity of Bruton's tyrosine kinase (BTK) and blocks the B cell antigen receptor signaling pathway, thereby inhibiting the proliferation and survival of malignant B cells and exerting anti-tumor effects. However, the drug may cause a range of side effects during treatment. Here are some common side effects and how to deal with them:

1. Hematological side effects: including thrombocytopenia, anemia, neutropenia, etc. These reactions are usually discovered through regular blood routine monitoring. If necessary, the drug dosage may need to be adjusted or supportive treatments such as blood transfusions and whitening drugs may be used.

2. Non-hematological side effects: such as nausea, diarrhea, fatigue, peripheral edema, rash, joint pain, musculoskeletal pain, etc. These reactions are generally mild and can be tolerated by most patients. For serious or persistent side effects, you should seek medical treatment promptly and take corresponding measures under the guidance of a doctor, such as adjusting drug dosage and giving symptomatic treatment drugs.

3. Special side effects: such as tumor lysis syndrome, etc. These reactions are rare but serious. If they occur, you should stop taking the drug and seek medical treatment immediately. Doctors will develop a personalized treatment plan based on the patient's specific situation to reduce or eliminate the impact of these serious side effects.

4. Infection: Ibrutinib may increase the risk of infection, especially opportunistic infections. Therefore, patients should pay attention to preventing infection during treatment, such as avoiding contact with infected patients and maintaining good personal hygiene habits. Once symptoms of infection appear, you should seek medical treatment promptly and inform the doctor that you are using ibrutinib.

It needs to be emphasized that patients should strictly follow medical instructions while using ibrutinib, take the medicine on time and in the right amount, and have regular follow-up reviews so that possible side effects can be discovered and dealt with in a timely manner. At present, this drug has been included in medical insurance in my country, and patients can be reimbursed. Generic drugs of ibrutinib are also sold overseas at very affordable prices. Patients please choose according to their needs.